Key Highlights

● CEG closed at $298.07 on 9 October 2026, up $13.00 or 4.56% on the day, and the second data set's $341.53 mean target implies upside of about 14.6%.

● Market data shows a higher $351.76 consensus implying roughly 18.0% upside, with targets from $277 to $441.

● Market data records 17 Buy, one Strong Buy and four Hold ratings with no Sell, a Moderate Buy consensus.

● Morgan Stanley raised to $369 from $364 on 18 September, while Bernstein reiterated Outperform with a $296 target on 6 October.

Constellation Energy Corporation (NASDAQ:CEG) is a member of both the S&P 500 and the Nasdaq-100. Its shares closed at $298.07 on Friday 9 October 2026, after rising $13.00 or 4.56% on the day. As one of the largest US nuclear generators, the company attracts close analyst attention, and published price targets sit well above the current price.

What Is the Latest Analyst Price Target?

The second data set, based on third-party data for 22 analysts, shows a mean price target of $341.53, a median of $345.50, a high of $395 and a low of $290. Against the $298.07 close, the mean suggests potential upside of about 14.6%. Market data shows a higher consensus of $351.76, with a high of $441.00 and a low of $277.00, implying roughly 18.0% upside.

The gap between providers largely reflects the extremes of the ranges. The $441 high target is well above anything in its list of recent named broker actions, where targets run from $296 to $374, and the average of those recent targets is closer to the the second data set figures.

What Are Wall Street Analysts Saying?

Ratings are positive. Market data records 17 Buy, one Strong Buy and four Hold ratings with no Sell ratings, a Moderate Buy consensus. The second data set shows 13 Strong Buy, six Buy and three Hold, with a consensus of Buy.

Recent named broker actions on market data include the following. Morgan Stanley raised its target from $364 to $369 on 18 September 2026 with an Overweight rating. Sanford C. Bernstein reiterated Outperform with a $296.00 target on 6 October, close to the current share price. Citigroup (8 October) and BMO Capital Markets (2 October) both reiterated positive ratings without targets being listed. BNP Paribas Exane reiterated Outperform with a $374.00 target on 19 August. Several brokers lowered targets in the summer: Argus from $350 to $325 on 11 August, UBS from $388 to $380 and Barclays from $358 to $324 on 28 July, and Wells Fargo from $384 to $362 and TD Cowen from $381 to $368 on 27 July.

What Could Prevent the Stock Reaching the Target?

The recent direction of target changes is a caution: most of the named brokers that changed targets over the summer lowered them. The stock's valuation depends heavily on long-dated power contracts and on the delivery of capacity expansions that are not expected until around 2028, which leaves room for delays or cost overruns. The share price also rose 4.56% on the final trading day, so some of the recent upside may already be reflected in the price.

Constellation's Targets Sit Above the Price While Summer Cuts Linger

Constellation closed at $298.07 on 9 October 2026 after a 4.56% gain, with the $341.53 mean target about 14.6% higher and market data's $441 high well above anything in its list of named broker actions, which run from $296 to $374. Ratings are positive, but most named brokers that changed targets over the summer lowered them, and Bernstein's $296 target is close to the current share price. The stock's valuation depends heavily on long-dated power contracts and capacity expansions not expected until around 2028.